Medical students' knowledge and awareness levels about biologics and biosimilars: the earlier the better?
Devrim Demir-DoraZinnet Şevval AksoyalpPublished in: Expert opinion on biological therapy (2021)
Our study showed that medical students had inadequate knowledge about biosimilars. We suggest that to establish a positive attitude toward prescribing biosimilars, knowledge about biologics and biosimilars should be delivered to physicians early, while they are still medical students, by including this topic into the medical curriculum.